New Enterprise Associates 17, L.P. 13D and 13G filings for Monte Rosa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-12 7:46 pm Sale | 2024-08-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,774,930 12.700% | -10,000 (-0.13%) | Filing |
| 2024-05-13 8:40 pm Purchase | 2024-05-09 | 13D | Monte Rosa Therapeutics, Inc. GLUE | New Enterprise Associates 17, L.P. | 7,784,930 15.400% | 7,784,930 (New Position) | Filing |